Antifungal Activities of Different Extracts of Marine Macroalgae Against Dermatophytes and Candida Species

Mycopathologia

Volumn 174, Issue 3, 2012, Pages 223-232

  Guedes, Elica Amara Cecilia ^a   dos Santos Araújo, Maria Anilda ^b   Souza, Aryanna Kelly Pinheiro ^b   de Souza, Larissa Isabela Oliveira ^b   de Barros, Lurdiana Dayse ^a   de Albuquerque Maranhão, Fernanda Cristina ^a   Sant'Ana, Antônio Euzébio Goulart ^a  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b Direito Público pela UFAL Especialista em Direito Penal e Processual Penal pela UCDB Direito Penal no Centro Universitário CESMAC Maceió AL   (Brazil)

Author keywords

Candida; Dermatophyte; Extracts; Macroalgae; Trichophyton

Indexed keywords

ANTIFUNGAL AGENT;

ARTHRODERMATACEAE; ARTICLE; BRAZIL; CANDIDA; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; SEAWEED;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; BRAZIL; CANDIDA; MICROBIAL SENSITIVITY TESTS; SEAWEED;

ALGAE; ARTHRODERMATACEAE; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANIS FAMILIARIS; FUNGI; MICROSPORUM CANIS; RHODOPHYTA; TRICHOPHYTON; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 84864276463     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9541-z     Document Type: Article

References (34)

1. Peres NTA, Maranhão FCA, Rossi A, Martinez-Rossi NM. Dermatophytes: host pathogen interaction and antifungal resistance. An Bras Dermatol. 2010; 85: 657-67.
2. Hay RJ, Jones RM. New molecular tools in the diagnosis of superficial fungal infections. Clin Dermatol. 2010; 4: 190-6.
3. Mota CRA, Miranda KC, Lemos JA, Costa CR, Hasimoto LKS, Passos XS, Meneses HS, Silva MR. Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods. Rev Soc Bras Med Trop. 2009; 42: 250-4.
4. Maranhão FC, Paião FG, Martinez-Rossi NM. Isolation of transcripts over-expressed in human pathogen Trichophyton rubrum during growth in keratin. Microbiol Pathog. 2007; 43: 166-72.
5. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008; 166: 335-52.
6. Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011; 3: 5771.
7. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Soberl JD. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of american. Clin Infect Dis. 2009; 48: 503-35.
8. Diogo HC, Sarpieri A, Melhem M, Pires MC. Evaluation of the disk-diffusion method to determine the in vitro efficacy of terbinafine against subcutaneous and superficial mycoses agents. An Bras Dermatol. 2010; 85: 324-30.
9. Tresoldi T, Barison EM, Pereira RM, Padoveze MC, Trabasso P. Risk factors associated witch the acquisition of multiresistant bacteria in pediatric nursery. J Pediatr. 2000; 4: 275-86.
10. Dovigo LN, Pavarina AC, Mima EGO, Giampaolo ET, Vergani CE, Bagnato VS. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses. 2009; 54: 123-30.
11. Mishra NN, Prasad T, Sharma N, Payasi A, Prasad R, Gupta DK, Singh R. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung. 2007; 54: 201-35.
12. Rizvi MA, Shameel M. Studies on the bioactivity and elementology of marine algae from the coast of Karachi. Pak Phyt Res. 2004; 18: 865-72.
13. Smit AJ. Medicinal and pharmaceutical uses of seaweed natural products: a review. J Appl Phycol. 2004; 16: 245-62.
14. Del Val GA, Platas G, Basilio A. Screening of antimicrobial activities in red, green and brown macoalgae from Gran Canaria (Gran Canary Islands, Spain). Int Microbiol. 2001; 4: 35-40.
15. Alves PM, Leite PAAS, Pereira JV, Pereira LF, Pereira MSV, Higino JS, Lima EO. Antifungal activity of the extract of Psidium guajava Linn. ("goiabeira") upon leavens of Candida of the oral cavity: an in vitro evaluation. Braz J Pharm. 2006; 16: 192-6.
16. Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican MA. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother. 2010; 65: 1514-20.
17. Guimarães KG. Dihydroisocoumarin from Xyris pterygoblephara active against dermatophyte fungi. Phytochemistry. 2008; 69: 439-44.
18. Sequeira BJ, Vital MJ, Pohlit AM, Pararols IC, Caúper GS. Antibacterial and antifungal activity of extracts and exudates of the Amazonian medicinal tree Himatanthus articulatus (Vahl) Woodson (common name: sucuba). Mem Inst Oswaldo Cruz. 2009; 104: 659-61.
19. Ostrosky EA, Mizumoto MK, Lima MEL, Kaneko TM, Nishikawa SO, Freitas BR. Methods for evaluation of the antimicrobial activity and determination of minimum inhibitory concentration (MIC) of plant extracts. Rev Bras Farmacogn. 2008; 18: 301-7.
20. Clinical and Laboratory Standard Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A, Wayne, PA. 2002.
21. Fernandez-Torres B, Cabanes FJ, Carrillo-Munoz AJ, Inza I, Guarro J. Collaborative evaluation of optimal antifungal susceptibility testing condition for dermatophytes. J Clin Microbiol. 2002; 40: 3999-4003.
22. Barros MES, Santos DA, Hamdan JS. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Clin Microbiol. 2007; 56: 514-18.
23. Clinical and Laboratory Standard Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeast fungi. Approved Standard Document M27-A, Wayne PA. 2008.
24. Chiheb I, Riadi H, Martinez-Lopez J, Dominguez SJF, Gomez VJA, Bouziane H, Kadiri M. Screening of antibacterial activity in marine green and brown macroalgae from the coast of Morocco. Afr J Biotechnol. 2009; 8: 1258-62.
25. Hellio C, Bremer G, Pons AM, Le Gal Y, Bourgougnon N. Inhibition of the development of microorganisms (bacteria and fungi) by extracts of marine algae from Brittany, France. Appl Microbial Biotechnol. 2000; 54: 543-9.
26. Ballesteros E, Martin D, Uriz MJ. Biological activity of extracts from some Mediterranean macrophytes. Bot Mar 1982; 35: 481-5.
27. Shanmughapriya S, Aseer M, Sugathan S, Kiran SJ, Seghal G, Kalimuthusamy N. Antimicrobial activity of seaweeds extracts against multiresistant pathogens. Ann Microbiol. 2008; 58: 535-41.
28. Sekine H, Ohonuki N, Sadamasu K. The inhibitory effect of the crude extract from a seaweed of Dygenea simplex C. Agardh on the in vitro cytopathic activity of HIV-1 and it's antigen production. Chem Pharm Bull. 1995; 43: 1580-4.
29. Bhakuni DS, Rawat DS. Bioactive marine natural products. USA: Anamaya Publishers and Springer; 2005. p. 346.
30. Melo VMM, Medeiros DA, Rios FJB, Castelar LIM, Carvalho AFFU. Antifungal properties of proteins (agglutinins) from the red algae Hypnea musciformis (Wulfen) Lamouroux. Bot Mar 1997; 40: 281-84.
31. Cordeiro RA, Gomes VM, Carvalho AFFUM, Maciel VM. Effect of Proteins from the Red Seaweed Hypnea musciformis(Wulfen) Lamouroux on the Growth of Human Pathogen Yeasts. Braz Arch Biol Technol 2005; 49: 915-21.
32. Tuney BH, Cadirci D, Ünal A, Sukatar A. Antimicrobial activities of the extracts of marine algae from the coast of Urla (Izmir, Turkey). Turk J Biol. 2006; 20: 171-5.
33. Salvador N, Garreta AG, Lavelli L, Ribera MA. Antimicrobial activity of Iberian macroalgae. Sci Mar. 2007; 71: 101-13.
34. Orandy MA, Verde MJ, Martinez-Lozano SJ, Waksman NH. Active fractions from species of marine algae. Intern J Exp Bot 2004; 165-70.